Nkarta, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
NKTX Nasdaq 2834 www.nkartatx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Nkarta, Inc.

Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation - May 14th, 2026 5:12 am
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights - May 12th, 2026 2:01 pm
NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program - Apr 17th, 2026 8:28 am
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers - Apr 15th, 2026 2:01 pm
Nkarta to Participate in Needham Virtual Healthcare Conference - Apr 9th, 2026 5:00 am
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights - Mar 25th, 2026 2:01 pm
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight - Mar 10th, 2026 3:31 pm
Nkarta to Participate in March Investor Conferences - Feb 27th, 2026 6:00 am
Stock Market Today, Jan. 21: ImmunityBio Rises Again As Short-Sellers Face Losses - Jan 21st, 2026 3:58 pm
We Think Nkarta (NASDAQ:NKTX) Needs To Drive Business Growth Carefully - Dec 4th, 2025 5:24 am
Nkarta to Participate in Evercore Healthcare Conference - Dec 2nd, 2025 5:09 am
Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - Nov 10th, 2025 2:01 pm
Nkarta to Participate in November Investor Conferences - Oct 30th, 2025 11:14 am
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies | DelveInsight - Oct 22nd, 2025 3:31 pm
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - Oct 22nd, 2025 8:07 am
Nkarta to Participate in a September Investor Conference - Sep 2nd, 2025 6:01 am
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - Aug 12th, 2025 2:01 pm
Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - Jul 23rd, 2025 6:01 am
Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely? - Jun 27th, 2025 5:04 am